EP. 1: Impact of AMD and DME on Quality of Life
David A. Eichenbaum, MD, FASRS, and Caroline Baumal, MD, discuss how AMD and DME impact a patient’s quality of life.
EP. 2: AMD and DME: Factors Affecting Treatment Selection and the Importance of Shared Decision-Making
Retina specialists discuss which factors impact treatment selection and how to incorporate shared decision-making into treatment selection when treating patients with AMD and DME.
EP. 3: Implications of Treat-and-Extend With Faricimab in AMD
Drs David A. Eichenbaum and Caroline Baumal discuss implications of the treat-and-extend approach with faricimab in patients with wet AMD.
EP. 4: MOA of Faricimab and 2-Year Data Review
David A. Eichenbaum, MD, FASRS, and Caroline Baumal, MD, review the dual mechanism of action of faricimab as well as the 2-year update in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials.
EP. 5: Incorporating Faricimab in Clinical Practice
Retina specialists discuss how to incorporate faricimab into clinical practice and discuss implacations of the TRUCKEE study.
EP. 6: Unmet Needs in AMD and DME
Drs David A. Eichenbaum and Caroline Baumal discuss unmet needs in treating AMD and DME.
EP. 7: Take-Home Points for the Treatment of AMD and DME
David A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
